A Phase 2 immunological bridging study assessing the non-inferiority of a new formulation of ETVAX®. A prospective double-blind, randomized study in healthy volunteers
An individually-randomized, double-blind, placebo-controlled phase 2b trial (OEV-128) examining the efficacy of oral inactivated ETVAX vaccine to prevent enterotoxigenic E. coli-associated diarrhoea in Gambian children ages 6 to 18 months.
100 项与 Scandinavian Biopharma Holding AB 相关的临床结果
0 项与 Scandinavian Biopharma Holding AB 相关的专利(医药)
100 项与 Scandinavian Biopharma Holding AB 相关的药物交易
100 项与 Scandinavian Biopharma Holding AB 相关的转化医学